NCT04733586

Brief Summary

hip arthralgia is a painful condition specially geriatric patients. Trail to alleviate pain using locoregional procedures

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
408

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 26, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 2, 2021

Completed
18 days until next milestone

Study Start

First participant enrolled

February 20, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2021

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
Last Updated

February 2, 2021

Status Verified

January 1, 2021

Enrollment Period

3 months

First QC Date

January 26, 2021

Last Update Submit

January 28, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • pain score

    Visual analogue scale

    one week and 3 months

Study Arms (2)

fascia iliaca group

ACTIVE COMPARATOR
Procedure: Sonar guided fascia iliaca

quadratus lumborum

ACTIVE COMPARATOR
Procedure: Sonar guided quadratus lumborum block

Interventions

Sonar guided fascia iliaca

fascia iliaca group

Sonar guided quadratus lumborum block

quadratus lumborum

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All candidates with hip arthalgia (primary or secondery)

You may not qualify if:

  • History of warfarin or clopidogrel adminstration .
  • patient on chemotherapy
  • Cognitive disrder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of anesthesia and ICU

Study Record Dates

First Submitted

January 26, 2021

First Posted

February 2, 2021

Study Start

February 20, 2021

Primary Completion

May 20, 2021

Study Completion

June 1, 2021

Last Updated

February 2, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share